Cas:117318-92-0 Poly[6-[4-(4-cyanophenyl)phenoxy]hexyl methacrylate] manufacturer & supplier

We serve Chemical Name:Poly[6-[4-(4-cyanophenyl)phenoxy]hexyl methacrylate] CAS:117318-92-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Poly[6-[4-(4-cyanophenyl)phenoxy]hexyl methacrylate]

Chemical Name:Poly[6-[4-(4-cyanophenyl)phenoxy]hexyl methacrylate]
CAS.NO:117318-92-0
Synonyms:MFCD04041022
Molecular Formula:N/A
Molecular Weight:N/A
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like MFCD04041022 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD04041022 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD04041022 Use and application,MFCD04041022 technical grade,usp/ep/jp grade.


Related News: On April 8, a group of employees filed an anonymous complaint internally alleging that an executive at its Branchburg, New Jersey, factory had altered documents required by the U.S. Food and Drug Administration. Poly[6-[4-(4-cyanophenyl)phenoxy]hexyl methacrylate] manufacturer For example, there are concerns that PFAS’ effect on the thyroid could lead to thyroid cancer, van Gerwen said. Poly[6-[4-(4-cyanophenyl)phenoxy]hexyl methacrylate] supplier On April 8, a group of employees filed an anonymous complaint internally alleging that an executive at its Branchburg, New Jersey, factory had altered documents required by the U.S. Food and Drug Administration. Poly[6-[4-(4-cyanophenyl)phenoxy]hexyl methacrylate] vendor Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday. Poly[6-[4-(4-cyanophenyl)phenoxy]hexyl methacrylate] factory On April 8, a group of employees filed an anonymous complaint internally alleging that an executive at its Branchburg, New Jersey, factory had altered documents required by the U.S. Food and Drug Administration.